–
Eloxx Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.0
FY22:
−34.4
FY23:
−17.3
FY24:
−2.47
FY25:
−6.44
(positive)
Change from FY21 to FY25
millions USD
FY21:
−65.1
FY22:
−33.4
FY23:
−16.5
FY24:
−2.22
FY25:
−6.28
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.7
FY22:
−36.1
FY23:
−17.1
FY24:
−3.14
FY25:
−6.00
(positive)
Change from FY21 to FY25
millions USD
FY21:
−66.7
FY22:
−36.1
FY23:
−17.1
FY24:
−3.14
FY25:
−6.00
All amounts in millions USD